Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Conception Age

Known as: Conceptual Age, Conceptional Age, Post-Conceptional Age 
The time elapsed between the day of conception and the day of delivery.(NICHD)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2005
Highly Cited
2005
Data from animal models indicate that neonatal stress or pain can permanently alter subsequent behavioral and/or physiological… Expand
Is this relevant?
Highly Cited
2002
Highly Cited
2002
OBJECTIVE To determine the efficacy of sucrose analgesia for procedural pain during the first week of life in preterm neonates in… Expand
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2000
Highly Cited
2000
A sample of infants was examined at conceptual age 67 weeks (6-month testing, N=230), and again at conceptual age 92 weeks (12… Expand
Is this relevant?
Highly Cited
2000
Highly Cited
2000
OBJECTIVES To assess the risk of hospitalization associated with respiratory syncytial virus (RSV) and to estimate the economic… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
Highly Cited
1997
Highly Cited
1997
The formation of synaptic contacts in human cerebral cortex was compared in two cortical regions: auditory cortex (Heschl's gyrus… Expand
Is this relevant?
Highly Cited
1996
Highly Cited
1996
OBJECTIVE To determine the effect of being in the neonatal intensive care unit (NICU) on pain responses in infants of 32 weeks… Expand
Is this relevant?
Highly Cited
1994
Highly Cited
1994
&NA; The threshold of a cutaneous withdrawal reflex, elicited by calibrated von Frcy hairs applied to the foot and leg, has been… Expand
Is this relevant?
Highly Cited
1988
Highly Cited
1988
Cutaneous flexor reflex thresholds have been used as a measure of somatosensory function: the authors measured threshold in… Expand
Is this relevant?
Review
1988
Review
1988
... .... .. .... ....... ........ .... ... .. .. ..... ....... .... ..... ... ........ ...... .. ....... ..... ... ... .. ...... .. .. .... ....... .. ... .. ... .. 190 I. Drug Absorption .. ........ .... ...... ..... .... .... .... ... .. ...... ..... ... ...... ... .... .. .. .... .. .. ....... .. ................... ... .... 191 1.1 Ontogeny of Gastric Acid Production ..... ....... .... ...... ... ....... ..... ........ ....... .. .... .... ... ... .. .... I 91 1.2 Gastric Emptying ................. ... ... ... ............ .... ..... .. .. .... .... .. ........ ..... .. ...... .... ..... ..... ... ..... .... 192 1.3 Absorption of Drugs Given Intramuscularly .................. ........... ... ....... ..... ... .......... ..... . I 94 1.4 Percutaneous Absorption .. .. .. .... .... ... ...... ........ ........... .. ..... .. ............ ...... .. ..... ....... ...... ...... 195 1.5 Rectal Absorption .......... ......... .... ...... .. .... ... .. .... ....... ...... ...... ... ........ ..... .... ..... ....... .. ..... ..... 196 2. Drug Distribution ...... ... .... .... .... ..... .... ......... ..... .................... .................................. ... ..... .... ... . 197 2.1 Developmental Aspects of Protein Binding ... ..... .. .... ..... ........ ........ .......... ......... ... .. .... .. 197 2.2 Influence of Endogenous Substances on Protein Binding ......... ...... .. ... .... .... ......... ... .. . 198 2.2. I Free Fatty Acids .. ........ ..... ...... ...... .... ... ...... .. .. .... ...... .. ... .. .... ... ..... ........ ......... .. ...... ... 199 2.2.2 Bilirubin ................... .... .... ... ... ....... ..... ... .. ............. ........ ...... ... .. ................... ... .......... I 99 2.3 Developmental Aspects of Auid Compartment Sizes ...... ... ... ... .... ........ ...... .......... ..... . 200 2.3. 1 Total Body Water .......... .... ........ ... ...... ... ....... ............. ..... .... ....... ...... ... ...... ........ ... .. 200 2.3.2 Extracellular Auid Volume ............ .. ........ .... ... ... ...... .. ........................................... 201 2.3.3 Intracellular Auid Volume .... ... ......... .. ..... .. ........... ....... .. .. ................ ................. .... 201 3. Hepatic Drug Metabolism .. ............. .. .. ... ...... ........ .... .. ... ........ .. ... ..... .... .... .. .... .. ............ ......... 201 3.1 Developmental Aspects of Hepatic Clearance .......... ........... ... ..... .... .. .... ... .... ...... .... .. .... 202 3.1.1 Drug Uptake ....... .. ... ..... .. .... ... .. .. ......... ...... ...... ... .. ........ .................. .......... .... .. ......... 202 3. I .2 Biotransformation Phase I Reactions ....... .......... ... ....... ..... ... .... ...... ..... ..... .... .. .. 203 3.1.3 Biotransformation Phase II Reactions ............ ... .. ... ..... .. .... .......... .... .... ......... .... 204 3.1.4 Development of Conjugation Pathways ...... ... .. .... ...... ...... .... ..... ....... .. ........ ... ....... 205 4. Drug Elimination .... ... .. ..... .... ....... ...... ..... ........ .. ... ... .. .. ........................... .... ..... ... ... ...... ... ........ 205 4.1 Renal Excretion ... ... .... ... .. ....... ........ .. .. ........ ..... ....... ... ..... ....... ....... ..... .. ... .. ...... .... ....... ... ... 206 4.1.1 Renal Blood Aow ....... .... ...... .............. ... .. .... ....... .. .......... .. ..... ... .. ... .. .... ....... ... ..... ... 206 4.1.2 Glomerular Filtration Rate ... .. .. .... ... ........... .... ... ... ......... ... ... ... ...... .................... .... 206 4.1.3 Development of Tubular Function ....... .... ..... ... .. ....... ..... .. .... ......... .... ....... .... ....... 207 5. Biodisposition of Specific Agents ....... ... ....... ....... ...... .. ..... ....... ....... ....... ....... ..... .... .. ........ .... . 208 5.1 Digoxin ..... ... ...... ...... ..... .... ..... .. .... ... ... .... ..... .... .. .. ......... .. ..... .. ............. .............................. 208 5.1 . 1 Digoxin-Like Immunoreactive Substance(s) ...... ....... .... ...... ......... .. ........ ............ .. 208 5.1.2 Absorption ..... ....... ... .... ...... ...................... ........ .. ..... ..... ... ... ... ... ........ ........ .. .. .... ..... .. 209 5.1.3 Distribution ......... ..... .... .. ... .... ... .. .... ..... .... ..... .......... ..... ....... ..... ............ ...... ...... .... ... 2I 0 
Is this relevant?
Highly Cited
1982
Highly Cited
1982
Summary: The composition of human milk from mothers delivering prematurely (PT) and at term (T) was studied over the first weeks… Expand
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?